Dermatological aspects of angiogenesis

Area of Science:

• Vascular Biology
• Oncology
• Dermatology

Background:

• Neovascularization is essential for tumor growth, supplying nutrients and removing waste.
• Tumor vessels form through sprouting, intussusception, or incorporation of endothelial precursor cells.
• Vascular quiescence in normal tissues is maintained by a balance between angiogenesis inhibitors and stimulators.

Purpose of the Study:

• To review the role of angiogenesis in cutaneous tumor growth, invasion, and metastasis.
• To discuss the balance of angiogenic factors and inhibitors in maintaining vascular quiescence.
• To explore therapeutic strategies targeting angiogenesis for treating cutaneous and vascular tumors.

Main Methods:

• Review of current literature on angiogenesis and lymphangiogenesis in cutaneous oncology.
• Analysis of the molecular mechanisms regulating tumor vascularization.
• Discussion of endogenous angiogenesis inhibitors and proangiogenic factors.

Main Results:

• Tumor angiogenesis is driven by increased secretion of angiogenic factors and decreased levels of inhibitors.
• Thrombospondin 1 and 2, along with vascular endothelial growth factor A, are key regulators of skin vascular quiescence.
• Targeting angiogenesis presents a promising therapeutic avenue for vascular tumors and solid cutaneous malignancies.

Conclusions:

• Modulating angiogenesis is a potential strategy for treating various skin cancers.
• Understanding the balance of angiogenic factors is crucial for developing effective cancer therapies.
• Further research into lymphangiogenesis in tumor progression is warranted.